Nitrate Formulations and Exercise Performance
Effects of Different Nitrate Formulations on Strength and Endurance Performance in Recreationally Trained Adults
2 other identifiers
interventional
15
1 country
1
Brief Summary
this study compares the acute effects of Nitrate and Nitrate plus citrulline supplementation on physical performance in recreationally trained males and females. This is a cross-over within-participant comparison design concluding three arms (i) 600 mg of Nitrate (N), ii) 600 mg Nitrate and Citrulline (NC) and (iii) Placebo (PL). Conditions N, NC and PL will be tested one week apart, considering a minimum washout period of 72 hours. Dependent variables:
- Number of completed repetitions to failure in squat using 75% of 1RM.
- Ventilatory thresholds (VT1) and (VT2) and Vo2 max from a progressive to exhaustion running test (PGT)
- Lactate post (within 1 min of having completed the PGT)
- Rating of perceived exertion (RPE) by the Borg 6-to-20-point scale recorded every 2 min and at the end of the PGT.
- Heart rate associated with VT1, VT2, and Vo2max - Heart rate maximum.
- Maximal aerobic speed (MAS): calculated from the average speed of the last 2 minutes of the PGT.
- time limit test at MAS (conducted after 15 min of having completed the PGT)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedMarch 27, 2025
July 1, 2024
3 months
July 23, 2024
March 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Strength
Ten maximum repetitions set in back squat using 75% of the previously determined maximal strength determined by the maximum amount of kg lifter in one sigulare repetitions
Day 4, 2.5 hours after ingesting the supplement
Maximum oxygen consumption (Vo2max)
The highest level of oxygen determined during a progressive to exhaustion running test on a treadmill (PGT)
through study completion up to 3 weeks
Secondary Outcomes (4)
Ventilatory thresholds (VT1) and (VT2)
15 minutes after completing the strength test
lactate
through study completion up to 3 weeks
Heart Rate
through study completion up to 3 weeks
Rate of Perceived Exertion
through study completion up to 3 weeks
Other Outcomes (1)
Maximal Aerobic Speed
through study completion up to 3 weeks
Study Arms (3)
Nitrate
EXPERIMENTALA gel providing 600 mg (9.6 mmol) of nitrate.
Nitrated and citrulline
EXPERIMENTALA gel, providing 600mg of nitrate (9.6 mmol) and 6 g of citrulline-malate
Placebo
PLACEBO COMPARATORPlacebo in gel format providing negligible amount of nitrate
Interventions
A four-day supplementation period, separated by one week including a 3-day washout period between conditions will be applied before conducting strength and endurance assessments Days 1 to 3 the randomly assigned supplement (N, NC, or PLA) will be ingested 2 hr before a standard low-volume training session including 3 sets of 8 to 10 reps of squat and deadlift using a very light load (e.g., own body mass) and flexibility exercises following by 5 min of running at self-paced intensity rated as light (12) with the rating of perceived exertion Borg Scale. Day 4: the assigned supplement will be ingested 2.5 h before the assessments Assessment of strength and endurance will be conducted
Eligibility Criteria
You may qualify if:
- Physically active participants with experience in resistance training performing squats and endurance running as habitual exercises
- Free from musculoskeletal limitations or injuries
- Agree not to ingest any other supplement during the study.
You may not qualify if:
- History of various metabolic conditions or diseases
- Use of a variety of medications, including but not limited to those with androgenic or anabolic effects or nutritional supplements known to affect training outcomes such as creatine, proteins, etc. within 6 weeks before the beginning of the study
- Current use of tobacco products.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Greenwichlead
- Crown Sport Nutritioncollaborator
Study Sites (1)
Sparrows Farm
Eltham, London, SE9 2BT, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fernando Naclerio
University of Greenwich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 23, 2024
First Posted
July 31, 2024
Study Start
August 1, 2024
Primary Completion
October 15, 2024
Study Completion
December 15, 2024
Last Updated
March 27, 2025
Record last verified: 2024-07